Skip to main content

Flavoxate Hydrochloride

Generic: Flavoxate Hydrochloride

Verified·Apr 23, 2026
Manufacturer
Recordati
NDC
0574-0115
ICD-10 indication
N30.90

Affordability Check

How much will you actually pay for Flavoxate Hydrochloride?

In 30 seconds, see every legitimate way to afford Flavoxate Hydrochloride — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Flavoxate Hydrochloride

What is this medication?

Flavoxate hydrochloride is a prescription medication categorized as a urinary tract antispasmodic. Its primary function is to relax the smooth muscles located within the bladder and urinary system to prevent involuntary spasms. By easing these muscle contractions, the medication helps relieve the physical distress and discomfort caused by inflammation or irritation of the bladder, prostate, or urethra.

Doctors typically prescribe this medication to treat symptoms such as painful or difficult urination, frequent trips to the bathroom, and an intense, immediate urge to urinate. It is also useful for managing excessive nighttime urination and general bladder pain. Because it focuses on symptom relief rather than killing bacteria, it is frequently used as a supportive treatment alongside antibiotics if a urinary tract infection is the underlying cause of the irritation.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for Flavoxate Hydrochloride. Official source: DailyMed (NLM) · Label effective May 31, 2023

Indications and usage
INDICATIONS AND USAGE Flavoxate HCl tablets are indicated for symptomatic relief of dysuria, urgency, nocturia, suprapubic pain, frequency and incontinence as may occur in cystitis, prostatitis, urethritis, urethrocystitis/urethrotrigonitis. Flavoxate HCl tablets are not indicated for definitive treatment, but are compatible with drugs used for the treatment of urinary tract infections.
Dosage and administration
DOSAGE AND ADMINISTRATION Adults and children over 12 years of age: One or two 100 mg tablets 3 or 4 times a day. With improvement of symptoms, the dose may be reduced. This drug cannot be recommended for infants and children under 12 years of age because safety and efficacy have not been demonstrated in this age group.
Contraindications
CONTRAINDICATIONS Flavoxate HCl tablets are contraindicated in patients who have any of the following obstructive conditions: pyloric or duodenal obstruction, obstructive intestinal lesions or ileus, achalasia, gastrointestinal hemorrhage and obstructive uropathies of the lower urinary tract.
Warnings
WARNINGS Flavoxate HCl should be given cautiously in patients with suspected glaucoma.
Adverse reactions
ADVERSE REACTIONS The following adverse reactions have been observed, but there are not enough data to support an estimate of their frequency. Gastrointestinal: Nausea, vomiting, dry mouth. CNS: Vertigo, headache, mental confusion, especially in the elderly, drowsiness, nervousness. Hematologic: Leukopenia (one case which was reversible upon discontinuation of the drug). Cardiovascular: Tachycardia and palpitation. Allergic: Urticaria and other dermatoses, eosinophilia and hyperpyrexia. Ophthalmic: Increased ocular tension, blurred vision, disturbance in eye accommodation. Renal: Dysuria.
Use in pregnancy
Pregnancy: Teratogenic Effects-Pregnancy Category B. Reproduction studies have been performed in rats and rabbits at doses up to 34 times the human dose and revealed no evidence of impaired fertility or harm to the fetus due to flavoxate HCl. There are, however, no well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Medicare Part D coverage

How Flavoxate Hydrochloride appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-04-30).

Covered by plans

7%

403 of 5,509 plans

Most common tier

Tier 2

On 55% of covering formularies

Prior authorization required

0%

of covering formularies

TierFormularies on this tierShare
Tier 1 (preferred generic)22
29%
Tier 2 (generic)42
55%
Tier 3 (preferred brand)3
4%
Tier 4 (non-preferred brand)10
13%

Step therapy: 0% of formularies

Quantity limits: 0% of formularies

Coverage breadth: 77 of 65 formularies

How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.